{
  "docId": "019de075-b7fd-707e-9848-cbfca2408f7c",
  "docSlug": "18b92232553b1610a38c1cd353f6efa7",
  "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 28 slides",
  "authorId": "matinas-biopharma",
  "authorName": "Matinas BioPharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 21,
  "pageCount": 28,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses a process-flow diagram to represent maturity levels (Proven, Under Evaluation, Future).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-b7fd-707e-9848-cbfca2408f7c/21",
  "deckHref": "/decks/019de075-b7fd-707e-9848-cbfca2408f7c",
  "deckJsonHref": "/decks/019de075-b7fd-707e-9848-cbfca2408f7c.json",
  "deckAnchorHref": "/decks/019de075-b7fd-707e-9848-cbfca2408f7c#slide-21",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.92,
        "x": 0.04,
        "y": 0.3
      },
      "kind": "diagram",
      "text": "Proven -> Under Evaluation -> Future",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "423e57a0-ed77-4556-92c7-329ea6c6669a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.3,
        "y": 0.45
      },
      "kind": "list",
      "text": "Intracellular Delivery of Nucleic Acids: siRNA, ASO, mRNA, DNA",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8eece210-7428-4a0c-8c63-2e46888fea37",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.35,
        "x": 0.58,
        "y": 0.35
      },
      "kind": "list",
      "text": "Potential Therapeutic Applications: Infection, Immune RX, Inflammation, Oncology, Pulmonary, Fibrosis",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9dd7e34d-016b-434e-a340-572f2f3d6a0f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "list",
      "text": "Oral Formulations of Anti-Infectives: MAT2203",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fb8c2c7b-b6f9-4888-b879-0ff69b208222",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.85,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "title",
      "text": "Matinas is working internally and with third parties to broaden its pipeline of LNC and PS-NP-based therapeutics",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b168014-1f83-4eaf-83ef-945d0adb6af0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.04,
        "y": 0.06
      },
      "kind": "title",
      "text": "Unlocking the Full Potential of the LNC and PS-NP Platforms",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d37438c4-57eb-4736-9685-7ddfba28659d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "8391ad27-a828-4e1a-a4c6-3a438d153c4a",
      "evidence": "The slide mentions potential therapeutic applications, suggesting an understanding of the target audience's needs.",
      "confidence": 0.5
    },
    {
      "name": "Three-Act Structure",
      "slug": "three-act-structure",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "264aa8af-7f56-4365-9a1d-dbc13bae0270",
      "evidence": "The slide presents a clear progression from current state to future potential, outlining the company's goals and objectives.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "maturity-model",
      "slug": null,
      "matchId": "bf3fe20c-0095-4648-a0de-40ed877d2884",
      "evidence": "Progression from Proven to Under Evaluation to Future",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}